Previous Close | 113.02 |
Open | 111.87 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 110.78 - 112.72 |
52 Week Range | 101.47 - 133.90 |
Volume | |
Avg. Volume | 1,523,939 |
Market Cap | 22.087B |
Beta (5Y Monthly) | 1.02 |
PE Ratio (TTM) | 21.17 |
EPS (TTM) | 5.24 |
Earnings Date | Feb 06, 2025 - Feb 10, 2025 |
Forward Dividend & Yield | 0.96 (0.87%) |
Ex-Dividend Date | Sep 30, 2024 |
1y Target Est | 124.92 |
Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This addition to the Persona family builds on Zimmer Biomet's commitment to personalized solutions, providing surgeons with advanced tools for revision knee arthroplasty.
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, we will look at where Zimmer Biomet Holdings, Inc. (NYSE:ZBH) ranks on the list of UBS’ bottom quant stocks. With November 2024 having settled in and the US presidential election in […]